• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Annette Powers… doomed leader





Reading these threads it does not surprise me (as a former Celgene employee) that she lacks the basic understanding about working in access. No payers know her or have even heard of her. She is not interested in getting to learn about them. Just a few snippets here and there from her team. Has rarely attended payer meetings. She is indeed naive when it comes to the access space no matter how much she talks it up.